Search
Twist Bioscience Corp
TWSTAdd to Watchlist
99.240USD
-3.010-2.94%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
6.17BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-2.94%
5 Days
-0.60%
1 Month
+34.24%
6 Months
+206.39%
Year to Date
+212.86%
1 Year
+159.99%
Key Figures
103.850Open
105.470High
1.52MVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.45%Turnover Ratio
102.250Prev. Close
97.520Low
114.43MTurnover
LossP/E Static
13.55P/B
0.00%Div Yield TTM
-12.78%ROA
69.20052wk High
1.17Volume Ratio
-77.67MNet Profit
62.15MShares
-1.3188EPS TTM
2.24Beta
-18.16%ROE
23.30052wk Low
7.77%Amplitude
51.59%Gross Margin
6.17BMarket Cap
10.13Reward/Risk
3.78%Risk Rate
TradingKey Stock Score of Twist Bioscience Corp
Currency: USD Updated: 2026-07-02Key Insights
Twist Bioscience Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 78.33.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Twist Bioscience Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
Twist Bioscience Corp Highlights
StrengthsRisks
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 53.63% year-on-year.
Undervalued
The company’s latest PE is -75.25, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 78.48M shares, decreasing 0.43% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 4.70M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.74.
Analyst Rating
Based on
10
analysts
Strong Buy
Current Rating
78.333
Target Price
-23.39%
Upside Space
Twist Bioscience Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Twist Bioscience Corp Info
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
Ticker SymbolTWST
CompanyTwist Bioscience Corp
CEOLeproust (Emily M)
Websitehttps://www.twistbioscience.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Twist Bioscience Corp (TWST)?
The current price of Twist Bioscience Corp (TWST) is 99.24.
What is the symbol of Twist Bioscience Corp?
The ticker symbol of Twist Bioscience Corp is TWST.
What is the 52-week high of Twist Bioscience Corp?
The 52-week high of Twist Bioscience Corp is 69.20.
What is the 52-week low of Twist Bioscience Corp?
The 52-week low of Twist Bioscience Corp is 23.30.
What is the market capitalization of Twist Bioscience Corp?
The market capitalization of Twist Bioscience Corp is 6.17B.
Is Twist Bioscience Corp (TWST) currently rated as Buy, Hold, or Sell?
According to analysts, Twist Bioscience Corp (TWST) has an overall rating of STRONG BUY, with a price target of 78.33.
What is the Earnings Per Share (EPS TTM) of Twist Bioscience Corp (TWST)?
The Earnings Per Share (EPS TTM) of Twist Bioscience Corp (TWST) is -1.30.